Skip to main content

Tourmaline Bio, Inc.

TRMLDelisted Oct 28, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001827506

Tourmaline Bio, Inc. was delisted on Oct 28, 2025; its insiders filed their last Form 4 on Oct 28, 2025; 134 institutions reported holding it in 13F filings for Q3 2025, worth $1.03B in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Tourmaline Bio, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of TRML: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders4851+3
Shares25.9M29.9M+4.00M (+15.5%)
Value$349.4M$456.7M+$107.3M (+30.7%)

New holders (12)

Institutions that held Tourmaline Bio, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to TRML in Q4 2021
InstitutionSharesValue% of portfolio
Qiming U.S. Ventures Management, LLC2,932,606$44.8M20.63%
Norges Bank272,614$4.17M0.00%
Altium Wealth Management LLC59,520$910.0K0.06%
Ensign Peak Advisors, Inc47,548$727.0K0.00%
Goldman Sachs Group Inc23,088$353.0K0.00%
Rhumbline Advisers14,304$219.0K0.00%
Manufacturers Life Insurance Company, The10,770$165.0K0.00%
ProShare Advisors LLC10,482$160.0K0.00%
MetLife Investment Management9,762$149.3K0.00%
Wells Fargo & Company8,642$132.0K0.00%
Metropolitan Life Insurance Co7,232$110.6K0.00%
Daiwa Securities Group Inc.121$2.00K0.00%

Sold out (9)

Institutions that held Tourmaline Bio, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of TRML in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Healthcare of Ontario Pension Plan Trust Fund76,800$1.04M
D. E. Shaw & Co., Inc.24,990$339.0K
Parametric Portfolio Associates LLC16,934$230.0K
Ghisallo Capital Management LLC15,000$203.0K
Caas Capital Management LP12,493$169.0K
Two Sigma Advisers, LP11,400$155.0K
Two Sigma Investments, LP10,796$146.0K
Captrust Financial Advisors198$3.00K
TCI Wealth Advisors, Inc.60$1.00K